Refined risk stratification in residual triple-negative breast cancer after neoadjuvant therapy using residual cancer burden class and lymphovascular invasion. - Lee TH; Lee H; Jang JY; Park W; Cho WK; Cho EY; Ahn JS; Park YH; Nam SJ; Kim SW; Lee JE; Kim H (Breast cancer research and treatment, 2026)